Nandini C Patel
7PUBLICATIONS
61CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease.Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton
|Aug 30, 2024
Discovery of SARS-CoV-2 papain-like protease (PLpro) inhibitors with efficacy in a murine infection model.Michelle R Garnsey, Matthew C Robinson, Luong T Nguyen
|Jun 07, 2024
Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease.Martin Pettersson, Douglas S Johnson, John M Humphrey
|Apr 30, 2024
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19.Charlotte M N Allerton, Joel T Arcari, Lisa M Aschenbrenner
|Feb 14, 2022
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and Humans.Heather Eng, Alyssa L Dantonio, Eugene P Kadar
|Nov 02, 2021
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson
Pageof 2
Frequent Collaborators
5 joint publications
Amit S Kalgutkar
4 joint publications
Britton Boras
4 joint publications
Li Di
3 joint publications
Matthew F Sammons
3 joint publications
Heather Eng
3 joint publications
Eugene P Kadar
2 joint publications
Dafydd R Owen
2 joint publications
Jonathan Novak
2 joint publications
Jisun Lee
2 joint publications
Brett L Hurst
